2023年

題名著者名掲載媒体
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.Numata S, Nakataki M, Hasegawa N, Takaesu Y, Takeshima M, Onitsuka T, Nakamura T, Edagawa R, Edo H, Miura K, Matsumoto J, Yasui-Furukori N, Kishimoto T, Hori H, Tsuboi T, Yasuda Y, Furihata R, Muraoka H, Ochi S, Nagasawa T, Kyou Y, Murata A, Katsumoto E, Ohi K, Hishimoto A, Inada K, Watanabe K, Hashimoto R.Neuropsychopharmacol Rep. 2021 (In Press)
Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition and Implication of CDH23 in Schizophrenia.Balan S, Ohnishi T, Watanabe A, Ohba H, Iwayama Y, Toyoshima M, Hara T, Hisano Y, Miyasaka Y, Toyota T, Shimamoto-Mitsuyama C, Maekawa M, Numata S, Ohmori T, Shimogori T, Kikkawa Y, Hayashi T, Yoshikawa TSchizophr Bull 2021 (In Press)
Two children exhibiting social withdrawal, school refusal, and underlying generalized anxiety disorder successfully treated using a selective serotonin reuptake inhibitor.Naoki Yamada, Yoshihiro Nakadoi, Ryosuke Fukuma, and Tetsuro Ohmori.The Journal of Medical Investigation　67: 355-357, 2020
Unmet need for major depressive disorders - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.Iida H, Iga J, Hasegawa N, Yasuda Y, Yamamoto T, Miura K, Matsumoto J, Murata A, Ogasawara K, Yamada H, Hori H, Ichihashi K, Hashimoto N, Ohi K, Yasui-Furukori N, Tsuboi T, Nakamura T, Usami M, Furihata R, Takaesu Y, Iwamoto K, Sugiyama N, Kishimoto T, Tsujino N, Yamada H, Hishimoto A, Nemoto K, Atake K, Muraoka H, Katsumoto E, Oishi S, Inagaki T, Ito F, Imamura Y, Kido M, Nagasawa T,Numata S, Ochi S, Iwata M, Yamamori H, Fujita J, Onitsuka T, Yamamura S, Makinodan M, Fujimoto M, Takayanagi Y, Takezawa K, Komatsu H, Fukumoto K, Tamai S, Yamagata H, Kubota C, Horai T, Inada K, Watanabe K, Kawasaki H, Hashimoto RPsychiatry Clin Neurosci. 74:667-669, 2020
Peritraumatic reactions, PTSD symptoms, and pain: A study of train disasters in Japan.Uchiumi C, Kato H, Ishida M, Nakataki M, Ohmori T.　J Med Invest. (in press)
Depression among adolescents: clinical features and interventions.Izaki. Y.J Med Invest. (in press)

2021年

題名著者名掲載媒体
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.Numata S, Nakataki M, Hasegawa N, Takaesu Y, Takeshima M, Onitsuka T, Nakamura T, Edagawa R, Edo H, Miura K, Matsumoto J, Yasui-Furukori N, Kishimoto T, Hori H, Tsuboi T, Yasuda Y, Furihata R, Muraoka H, Ochi S, Nagasawa T, Kyou Y, Murata A, Katsumoto E, Ohi K, Hishimoto A, Inada K, Watanabe K, Hashimoto R.Neuropsychopharmacol Rep. 2021 (In Press)
Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition and Implication of CDH23 in Schizophrenia.Balan S, Ohnishi T, Watanabe A, Ohba H, Iwayama Y, Toyoshima M, Hara T, Hisano Y, Miyasaka Y, Toyota T, Shimamoto-Mitsuyama C, Maekawa M, Numata S, Ohmori T, Shimogori T, Kikkawa Y, Hayashi T, Yoshikawa TSchizophr Bull 2021 (In Press)
Two children exhibiting social withdrawal, school refusal, and underlying generalized anxiety disorder successfully treated using a selective serotonin reuptake inhibitor.Naoki Yamada, Yoshihiro Nakadoi, Ryosuke Fukuma, and Tetsuro Ohmori.The Journal of Medical Investigation　67: 355-357, 2020
Unmet need for major depressive disorders - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.Iida H, Iga J, Hasegawa N, Yasuda Y, Yamamoto T, Miura K, Matsumoto J, Murata A, Ogasawara K, Yamada H, Hori H, Ichihashi K, Hashimoto N, Ohi K, Yasui-Furukori N, Tsuboi T, Nakamura T, Usami M, Furihata R, Takaesu Y, Iwamoto K, Sugiyama N, Kishimoto T, Tsujino N, Yamada H, Hishimoto A, Nemoto K, Atake K, Muraoka H, Katsumoto E, Oishi S, Inagaki T, Ito F, Imamura Y, Kido M, Nagasawa T,Numata S, Ochi S, Iwata M, Yamamori H, Fujita J, Onitsuka T, Yamamura S, Makinodan M, Fujimoto M, Takayanagi Y, Takezawa K, Komatsu H, Fukumoto K, Tamai S, Yamagata H, Kubota C, Horai T, Inada K, Watanabe K, Kawasaki H, Hashimoto RPsychiatry Clin Neurosci. 74:667-669, 2020
Peritraumatic reactions, PTSD symptoms, and pain: A study of train disasters in Japan.Uchiumi C, Kato H, Ishida M, Nakataki M, Ohmori T.　J Med Invest. (in press)
Depression among adolescents: clinical features and interventions.Izaki. Y.J Med Invest. (in press)

2020年

題名著者名掲載媒体
Differences in male climacteric symptoms and lifestyle depending on the duration of working among rotating night shift workers.Kubo S, Yasui T, Okahisa R, Matsuura Y, Tomotake M.Health. 1598-1609, 2020.
Decelerated epigenetic aging associated with mood stabilizers in the blood of patients with bipolar disorder.Okazaki S, Numata S, Otsuka I, Horai T, Kinoshita M, Sora I, Ohmori T, Hishimoto A.Transl Psychiatry. 10(1):129, 2020
Association between serum folate levels and schizophrenia based on sex.Tomioka Y, Kinoshita M, Umehara H, Nakayama T, Watanabe SY, Nakataki M, Numata S, Ohmori T.Psychiatry Clin Neurosci. 2020 74(9):466-471, 2020
Behavioral and psychological symptoms of dementia (BPSD) and care burden : Examination in the facility staff for elderly residents.Kameoka N, Sumitani S, Ohmori T.J Med Invest. 67(3.4):236-239, 2020
Two children exhibiting social withdrawal, school refusal, and underlying generalized anxiety disorder successfully treated using a selective serotonin reuptake inhibitor.Yamada N, Nakadoi Y, Fukuma R, Ohmori T .J Med Invest. 67(3.4):355-357, 2020
Predictors of life skills in people with schizophrenia.Tominaga T, Tomotake M, Takeda T, Ueoka Y, Tanaka T, Watanabe SY, Kameoka N, Nakataki M, Numata S, Izaki Y, Sumitani S, Kubo H, Kaneda Y, Ohmori T.J Med Invest 67:75-82, 2020
White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals.Koshiyama D, Fukunaga M, Okada N, Morita K, Nemoto K, Usui K, Yamamori H, Yasuda Y, Fujimoto M, Kudo N, Azechi H, Watanabe Y, Hashimoto N, Narita H, Kusumi I, Ohi K, Shimada T, Kataoka Y, Yamamoto M, Ozaki N, Okada G, Okamoto Y, Harada K, Matsuo K, Yamasue H, Abe O, Hashimoto R, Takahashi T, Hori T, Nakataki M, Onitsuka T, Holleran L, Jahanshad N, van Erp TGM, Turner J, Donohoe G, Thompson PM, Kasai K, Hashimoto R; COCORO.Mol Psychiatry　25(4):883-895, 2020
Glucocorticoids and cortical decoding in the phobic brain.Schwab S, Federspiel A, Morishima Y, Nakataki M, Strik W, Wiest R, Heinrichs M, de Quervain D, Soravia LM.Psychiatry Res Neuroimaging. 31;300:111066, 2020 
Can Pallidal Deep Brain Stimulation Rescue Borderline Dystonia? Possible Coexistence of Functional (Psychogenic) and Organic Components.Morigaki R, Miyamoto R, Mure H, Fujita K, Matsuda T, Yamamoto Y, Nakataki M, Okahisa T, Matsumoto Y, Miyake K, Yamamoto N, Kaji R, Takagi Y, Goto S.Brain Sci. 15;10(9):636, 2020
Structural variation in the glycogen synthase kinase 3β and brain-derived neurotrophic factor genes in Japanese patients with bipolar disorders.Suga Y, Yoshimoto K, Numata S, Shimodera S, Takamura S, Kamimura N, Sawada K, Kazui H, Ohmori T, Morinobu S.Neuropsychopharmacol Rep　40(1):46-51, 2020
Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia.Kudo N, Yamamori H, Ishima T, Nemoto K, Yasuda Y, Fujimoto M, Azechi H, Niitsu T, Numata S, Ikeda M, Iyo M, Ohmori T, Fukunaga M, Watanabe Y, Hashimoto K, Hashimoto R.Neuropsychopharmacol Rep. 40:150-156, 2020
ABCA7 Gene Expression and Genetic Association Study in Schizophrenia.Yamazaki K, Yoshino Y, Kawabe K, Ibuki T, Ochi S, Mori Y, Ozaki Y, Numata S, Iga JI, Ohmori T, Ueno SI.Neuropsychiatr Dis Treat　13;16:441-446, 2020

2019年

題名著者名掲載媒体